期刊文献+

嗜麦芽窄食单胞菌的临床分布与耐药性分析 被引量:3

在线阅读 下载PDF
导出
摘要 目的了解嗜麦芽窄食单胞菌(Stenotrophomonasmaltophilia)的临床分布及耐药性。方法对117株初次分离的嗜麦芽窄食单胞菌进行临床分析,并采用法国生物梅里埃公司VITEK全自动微生物鉴定仪进行鉴定和药敏测试。结果117例嗜麦芽窄食单胞菌感染患者平均年龄60岁,标本主要来源于痰(88株)、血液(19株)。科室分布居前四位的依次为ICU、肝胰移植病房、呼吸内科、血液科。13种抗菌药物中哌拉西林/他唑巴坦、左氧氟沙星、头孢替坦、头孢他啶对嗜麦芽窄食单胞菌有较强的抗菌活性,敏感率分别为93.2%、89.7%、76.9%、76.1%。头孢唑啉、头孢曲松、氨曲南对嗜麦芽窄食单胞菌的抗菌活性较低,耐药率分别为天然耐药、100%、76.9%、71.8%。结论嗜麦芽窄食单胞菌常在老年、免疫力低下等易感人群中引起呼吸道感染,对多种抗菌药物耐药。
出处 《江西医学检验》 2005年第3期227-228,共2页 Jiangxi Journal of Medical Laboratory Sciences
  • 相关文献

参考文献3

二级参考文献13

  • 1[2]Denton M,Kerr KG. Microbiological and clinical aspects of infection associated with Stenotrophomonas maltophilia[J]. Clin Microliol Rev, 1998,11 : 57-80
  • 2[3]National Committee for Clinical Laboratory Stardards. Performance standards for antimicrobial susceptibility testing[S]. Fourteenth Informational Supplement 2004 , M100-s14,24 : 36-38
  • 3[4]Pankuch GA,Jacobs MR,Rittenhouse SF,et al. Susceptibilities of 123 strains of Xanthomonas to eight beta-lactams (including beta-lactam-beta-lactamase inhibitor combinations) and ciprofloxacin tested by five methods[J]. Antimicrob Agent Chemother,1994,38 : 2317-2322.
  • 4[5]National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically[S]. Approved standard M7-A4, National Committee for Clinical Laboratory Standards, Villanova, Pa, 1997
  • 5[6]Yao JD, Louie M, Louie L, et al. Comparison of E test and agar dilution for antimicrobial susceptibility testing of Stenotrophomonas (Xanthomonas) maltophilia[J]. J Clin Microbio, 1995,33 : 1428-1430
  • 6National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing[S]. Tenth informational supplement M 100-S1 3,2003.
  • 7Segatore B, Setacci D, Perilli M, et al. Italian Survey on Comparative Levofloxacin Susceptibility in 334 Clinical Isolates of Pseudomonas aeruginosa [J]. Antimicrobial Agents and Chemotherapy,1999, 43(2):428~43 1.
  • 8Segatore B, Setacci D, Perilli M, et al. Italian survey on comparative levofloxacin suscptibility in 334 clinical isolates of Psoudomonas aeruginosa[J]. Antimicrobial Agents and Chemotherapy, 1999,43(2):428~431.
  • 9Gesu GP, Marchetti F, Piccoli L, et al. Levofloxacin and Ciprofloxacin In Vitro Activities against 4,003 Clinical Bacterial Isolates Collected in 24 Italian Laboratories[J]. Antimicrobial Agents and Chemotherapy, 2003, 47(2):816~819.
  • 10Betriu C, Rodriguez-Avial I, Sanchez BA, et al. In Vitro Activities of Tigecycline (GAR-936) against Recently Isolated Clinical Bacteria in Spain[J]. Antimicrobial Agents and Chemotherapy. 2002, 46(3):892~895.

共引文献10

同被引文献14

引证文献3

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部